We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$459B
AUM Growth
+$54.2B
Cap. Flow
+$12.6B
Cap. Flow %
2.74%
Top 10 Hldgs %
17.11%
Holding
10,551
New
1,100
Increased
4,831
Reduced
3,043
Closed
1,106

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$1.07B
2
TSLA icon
Tesla
TSLA
+$467M
3
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$262M
4
MTCH icon
Match Group
MTCH
+$241M
5
VLO icon
Valero Energy
VLO
+$212M

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.6%
2 Technology 16.89%
3 Financials 8.35%
4 Healthcare 6.45%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBI
6051
Trueblue
TBI
$287M
$151K ﹤0.01%
19,128
+7,433
+64% +$66.9K
CDLX icon
6052
Cardlytics
CDLX
$19.4M
$151K ﹤0.01%
4,715
+726
+18% +$40.3K
VLGEA icon
6053
Village Super Market
VLGEA
$672M
$151K ﹤0.01%
4,741
+1,473
+45% +$43.7K
OPPJ
6054
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$342M
$150K ﹤0.01%
4,429
-59,500
-93% -$1.99M
LYEL icon
6055
Lyell Immunopharma
LYEL
$241M
$150K ﹤0.01%
5,436
+1,195
+28% +$35.1K
CZA icon
6056
Invesco Zacks Mid-Cap ETF
CZA
$174M
$150K ﹤0.01%
1,384
-1,510
-52% -$154K
PFL
6057
PIMCO Income Strategy Fund
PFL
$346M
$150K ﹤0.01%
17,486
+368
+2% +$3.06K
ESPR
6058
DELISTED
Esperion Therapeutics
ESPR
$149K ﹤0.01%
90,293
+22,117
+32% +$44.7K
DBAW icon
6059
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$331M
$149K ﹤0.01%
4,269
– –
LUCY icon
6060
Innovative Eyewear
LUCY
$8.18M
$149K ﹤0.01%
17,837
+14,767
+481% +$88K
ETHD
6061
ProShares UltraShort Ether ETF
ETHD
$44.4M
$149K ﹤0.01%
+261
New +$156K
RIGL icon
6062
Rigel Pharmaceuticals
RIGL
$900M
$148K ﹤0.01%
+9,176
New +$108K
HBB icon
6063
Hamilton Beach Brands
HBB
$501M
$148K ﹤0.01%
4,860
+1,032
+27% +$25.2K
QMAR icon
6064
FT Vest Growth-100 Buffer ETF March
QMAR
$604M
$148K ﹤0.01%
5,164
+4,596
+809% +$128K
GOSS icon
6065
Gossamer Bio
GOSS
$66.9M
$148K ﹤0.01%
1,873
+1,872
+187,200% +$144K
EMF
6066
Templeton Emerging Markets Fund
EMF
$333M
$148K ﹤0.01%
10,904
-6,533
-37% -$82.8K
THRD
6067
DELISTED
Third Harmonic Bio
THRD
$147K ﹤0.01%
10,885
+3,104
+40% +$38.5K
AXTI icon
6068
AXT Inc
AXTI
$5.18B
$147K ﹤0.01%
60,872
+46
+0.1% +$130
XJAN icon
6069
FT Vest US Equity Enhance & Moderate Buffer ETF January
XJAN
$40.3M
$147K ﹤0.01%
4,419
+4,411
+55,138% +$144K
HUCK
6070
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$159M
$146K ﹤0.01%
19,490
-6,433
-25% -$49.1K
NKTR icon
6071
Nektar Therapeutics
NKTR
$1.95B
$146K ﹤0.01%
7,501
+3,667
+96% +$69.9K
ACTG icon
6072
Acacia Research
ACTG
$417M
$146K ﹤0.01%
31,372
+13,291
+74% +$65.7K
FVNNU
6073
Future Vision II Acquisition Corp Units
FVNNU
$53.8M
$146K ﹤0.01%
+14,600
New +$146K
NYAX
6074
Nayax
NYAX
$1.68B
$146K ﹤0.01%
5,788
-8,875
-61% -$210K
LENZ
6075
LENZ Therapeutics
LENZ
$123M
$146K ﹤0.01%
6,145
+2,083
+51% +$46.2K

Similar funds

UBS Group's Q3 2024 Portfolio in Review

As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group's Q3 2024 filing shows 1,100 new, 4,831 increased, 3,043 reduced and 1,106 closed positions. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M. The largest sale was Nike, an estimated $1.07B.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 42% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
  • UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
  • UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
  • UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
  • UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
  • UBS Group opened 1,100 new positions and closed 1,106 in Q3 2024.
  • UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.